iShares U.S. Pharmaceuticals ETF Rating $91.51 0.00 (0.00%) As of 05/22/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy 2.72Holdings in IHE have an aggregate rating of Moderate Buy based on 328 analyst ratings issued in the past year covering 25 companies (91.9% of the portfolio).IHE Aggregate Price Target$91.51High Prediction$91.51Average Prediction$91.51Low Prediction$91.51Holdings in IHE have an aggregate price target of $91.51 and a range of $91.51 to $91.51 covering 25 companies (91.9% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IHE Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings22.96%LLYEli Lilly and Company$1,066.59+0.1%4.82 of 5 stars2.87$1,220.37 14.4%30Trending NewsAnalyst Forecast21.32%JNJJohnson & Johnson$234.67+0.1%4.3407 of 5 stars2.74$253.04 7.8%27Positive News5.29%VTRSViatris$16.652.2297 of 5 stars2.38$16.43 -1.3%8Ex-Dividend5.17%RPRXRoyalty Pharma$54.504.0029 of 5 stars3.00$53.71 -1.4%74.38%MRKMerck & Co., Inc.$122.55+0.1%4.3923 of 5 stars2.68$128.18 4.6%194.34%BMYBristol Myers Squibb$59.51+0.1%4.7431 of 5 stars2.37$61.31 3.0%19Positive News4.24%PFEPfizer$25.92+0.1%3.9162 of 5 stars2.19$28.61 10.4%213.88%JAZZJazz Pharmaceuticals$239.832.549 of 5 stars2.84$241.53 0.7%19Analyst Forecast2.83%ZTSZoetis$81.26-0.1%4.9841 of 5 stars2.40$133.92 64.8%15Dividend AnnouncementAnalyst Forecast2.75%ELANElanco Animal Health$21.77+0.2%4.6468 of 5 stars2.77$28.20 29.5%13Analyst Downgrade2.69%AXSMAxsome Therapeutics$235.972.6163 of 5 stars2.90$251.26 6.5%211.47%CORTCorcept Therapeutics$60.223.8462 of 5 stars2.75$70.83 17.6%8Analyst Revision1.28%INDVIndivior$37.533.5155 of 5 stars3.00$39.33 4.8%71.17%LGNDLigand Pharmaceuticals$229.333.5981 of 5 stars2.88$257.71 12.4%8Positive NewsGap Down1.09%LQDALiquidia$60.983.2521 of 5 stars2.92$49.33 -19.1%121.05%CRNXCrinetics Pharmaceuticals$36.802.3731 of 5 stars2.90$76.13 106.9%100.97%OGNOrganon & Co.$13.44+0.0%2.9537 of 5 stars1.71$11.40 -15.1%70.79%SUPNSupernus Pharmaceuticals$48.213.7182 of 5 stars2.43$62.17 28.9%7Analyst DowngradeGap Up0.68%TARSTarsus Pharmaceuticals$62.263.4579 of 5 stars2.78$90.67 45.6%90.68%EWTXEdgewise Therapeutics$32.701.9465 of 5 stars2.89$39.67 21.3%90.62%NKTRNektar Therapeutics$66.613.0015 of 5 stars2.73$149.63 124.6%110.62%PBHPrestige Consumer Healthcare$48.02+0.0%3.9041 of 5 stars2.17$70.75 47.3%60.58%DFTXDefinium Therapeutics$22.502.9664 of 5 stars3.00$37.92 68.5%150.56%AMRXAmneal Pharmaceuticals$12.424.2744 of 5 stars2.88$15.17 22.1%80.52%ALMSAlumis$22.023.7562 of 5 stars2.83$40.30 83.0%12 This page (NYSEARCA:IHE) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
